PGNY insider notice: 2,500 common shares to be sold via Fidelity on 08/11/2025

Rhea-AI Filing Summary

Progyny (PGNY) filed a Form 144 notifying a proposed sale of 2,500 shares of its common stock, with an aggregate market value of $55,087.50, through Fidelity Brokerage Services LLC on 08/11/2025. The shares were acquired on 10/24/2021 via restricted stock vesting and were granted as compensation; the filer reports no securities sold in the past three months.

The filing includes the issuer's outstanding share count of 85,982,409, making the proposed sale a very small fraction of outstanding stock. The notice includes the filer’s representation that no undisclosed material adverse information about the issuer is known.

Insights

Securities Analyst

TL;DR: Routine small insider sale: 2,500 shares ($55k) from vested restricted stock, immaterial relative to 85.98M shares outstanding.

The filing documents a proposed sale executed through Fidelity and specifies the shares were obtained via restricted stock vesting on 10/24/2021 as compensation. Relative to the reported 85,982,409 shares outstanding, the 2,500-share sale represents approximately 0.0029% of outstanding stock, indicating this is unlikely to move the market or materially affect shareholder value. The filer also certifies no undisclosed material adverse information.

Corporate Governance Expert

TL;DR: Governance process followed: Form 144 filed for a compensatory restricted-stock sale via broker; disclosure appears complete for this notice.

The notice discloses acquisition date, nature of acquisition (restricted stock vesting), broker details (Fidelity Brokerage Services LLC), and the proposed sale date, meeting Form 144 disclosure requirements. The filer affirms the absence of undisclosed material adverse information, which is a standard certification on this form. Given the small size of the transaction, there is no indication here of governance concerns or material insider liquidity events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2500	55087.50	85982409	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/24/2021	Restricted Stock Vesting	Issuer			2500	10/24/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Progyny (PGNY) disclose in the Form 144 filing?

PGNY disclosed a proposed sale of 2,500 common shares with aggregate market value of $55,087.50, to be sold via Fidelity on 08/11/2025.

Who is the broker listed on the PGNY Form 144?

Fidelity Brokerage Services LLC (900 Salem Street Smithfield RI 02917) is listed as the broker for the proposed sale.

When were the 2,500 shares acquired according to the Form 144?

The shares were acquired on 10/24/2021 through restricted stock vesting and the payment nature is listed as compensation.

How large is the proposed sale relative to PGNY's outstanding shares?

The filing reports 85,982,409 shares outstanding; the 2,500-share sale represents approximately 0.0029% of outstanding shares.

Did the filer report any securities sold in the past three months on the PGNY Form 144?

No. The filing states "Nothing to Report" for securities sold during the past three months.